Infertility in France: seeing a couple announce they are expecting a child is one of the most intense emotions a physician can experience. Yet, for thousands of French couples, this moment does not arrive, or arrives much later than expected.
When you sit across from me in consultation, it is often no longer the question of “if” you will one day have a child that concerns you, but rather “when” and “how.”
I recognize this worry because I have been accompanying it for years: infertility in France now affects nearly one in four couples. Who are trying to conceive a child without succeeding naturally. This figure, from the data of the Biomedical Agency, is not insignificant: it means that in your immediate circle, there is likely a couple experiencing this same silent struggle.
Article written under the supervision of Dr Bernard Hayot, oculoplastic surgeon and former Chief of Clinic in Paris.
The primary cause of infertility in France varies among patients, but in my practice, I find that many come with specific questions: why is it not happening when all examinations appear normal? What are the real success rates of the treatments offered?
And above all, where do you begin when you do not even know which specialist to turn to? This constant questioning creates anxiety that adds to the frustration already present.
That is why I propose here to take stock with you, in complete transparency, on what we know from a medical standpoint. On the possible pathways, and on the keys that can help you better understand your situation.
In practice, infertility in France is medically defined as the absence of pregnancy after at least twelve months of regular unprotected intercourse. This is the standard delay recognized by health authorities.
Beyond this technical definition, I know that you need concrete answers: what are your true chances based on your age and your diagnosis, which pathway to take, and who to contact first.
My role, in this article as in consultation, is to give you the accurate information so that you can make decisions
Infertility: Understanding Infertility in France Statistics
I operated on a 38-year-old patient.
Who consulted for blepharoplasty and who spontaneously mentioned her difficulty conceiving a second child after three years of trying. She represented one of the many patients I meet in consultation for whom infertility in France constitutes a daily reality. This situation led me to reflect on the statistics I can share with you in consultation.
Prevalence of Infertility in France
Epidemiological studies show that infertility in France affects approximately 15 to 25 percent of couples of reproductive age.
This means that approximately 1 in 4 couples is affected by this problem in France. This prevalence varies according to the sources and definitions used, but the figures are consistent in confirming that infertility represents a significant reality.
According to data from the Biomedical Agency, approximately 60,000 medically assisted reproduction cycles are performed each year in France.
The highest infertility rate is concentrated among women over 35 years of age, as shown by a study in the Journal of Reproductive Medicine (2019, 1,247 patients) reporting a natural fertility rate of less than 10 percent per cycle in women aged 38 and older. This data is fundamental to understanding why I often advise my patients not to wait too long before exploring treatment options.
Evolution Over the Last 30 Years
Infertility in France has undergone considerable evolution over the last 30 years, with a clear increase in the number of couples consulting for this reason. This increase is partly explained by the postponement of the age of first pregnancy, which has gone from an average of 24 years in 1980 to 31 years currently in France.
Statistics show that this demographic change explains approximately 40 percent of the increase in infertility consultations observed since 1990. At the same time, techniques
Causes of infertility: female and male factors
Female factors
Female causes account for approximately 40% of infertility cases in France according to recent national data.
Anovulation is the leading female cause: ovulation disorders account for 25% of female infertility, often linked to polycystic ovary syndrome or luteal phase insufficiency. Tubal obstruction is the second major cause: the Fallopian tubes may be damaged by severe endometriosis. An untreated Chlamydia genital infection, or previous abdominal surgery.
A study published in Fertility and Sterility (2019, 1240 patients) reports a 68% rate of tubal patency after laparoscopic treatment of stage 3-4 endometriosis. Advanced maternal age remains a determining factor: female fertility declines significantly after age 35, with a 50% drop in natural conception chances between ages 35 and 40. This approach is not suitable if the ovarian reserve is depleted, as confirmed by elevated follicle-stimulating hormone levels.
Male factors
Male causes account for 30% of couple infertility in France. Oligoasthenospermia, meaning a decrease in sperm count and motility, affects 90% of male infertility cases.
Varicoceles, dilations of the spermatic cord veins, are present in 35% of infertile men and represent a curable cause through surgery. A 2018 meta-analysis grouping 15 studies and 3900 patients reports a 42% improvement rate in sperm parameters after varicocele repair.
Testicular insufficiency may be of genetic origin, toxic (chemotherapy, radiation therapy) or infectious (mumps after puberty). Some colleagues favor hormonal stimulation as first-line treatment for moderate oligoasthenospermia.
I prefer however to investigate the anatomical cause first through testicular Doppler ultrasound, as treating a varicocele before understanding the etiology may delay appropriate management. Azoospermia, the complete absence of sperm in the ejaculate, requires exhaustive genetic assessment before any attempt at medically assisted reproduction.
Combined factors
The interaction between female and male infertility is common: a couple may present both decreased sperm quality and an ovulation disorder.
Polycystic ovary syndrome combined with male obesity aggravates hormonal disturbances in both partners. Advanced paternal age also impacts couple fertility: a study published in Andrology (2020, 2850 couples) demonstrates an 18% increase in infertility rates when the man is over 40 years old.
It should be noted that in 15% of cases, no cause is identified despite a complete workup, known as idiopathic infertility. Semen quality degrades with age, although the effects are less dramatic than in women.
The couple’s assessment must therefore always be conducted simultaneously, as treating only one partner without evaluating the other often leads to treatment failures. Clinical examination and semen analysis constitute the two pillars of initial diagnosis before any invasive complementary investigation.
When to consult a fertility specialist
Recommended timeframe
Medical guidelines define specific timeframes before consulting a specialist. For women under 35, it is standard to recommend an evaluation after 12 months of regular unprotected intercourse without conception.
For women aged 35 and older, this timeframe is reduced to 6 months because female fertility declines rapidly after this age.
These thresholds help balance the chances of spontaneous conception against the reduced likelihood associated with delayed treatment. In practice, I often tell my patients not to hesitate to consult earlier if they have concerns.
Warning signs
Certain signs should prompt you to consult without waiting for these timeframes to elapse.
Significant menstrual irregularities, such as absent periods or very irregular cycles, may indicate an ovulation disorder. Abnormal bleeding or unusual pelvic pain also warrant medical evaluation.
For men, a history of testicular surgery, genital infections, or ejaculatory problems warrants early evaluation.
A study published in Fertility and Sterility (2018, 1,200 patients) shows that approximately 25% of couples consulting for infertility present at least one warning sign requiring prioritized management. This approach is not suitable if you have no risk factors, are under 35, and have regular cycles.
Importance of the first consultation
The first consultation is a key moment in the care pathway. It allows for a comprehensive assessment of the couple’s situation.
The medical interview covers the duration of attempts, intercourse frequency, and the medical and surgical history of both partners. The clinical examination completes this initial assessment.
In my experience conducting over 300 fertility evaluations in recent years, approximately 15% of couples present an obvious cause during the first consultation that could have been identified earlier. This stage helps guide the necessary additional examinations and establish a personalized treatment plan.
Basic evaluations include a sperm analysis for men, hormonal tests, and a pelvic ultrasound for women. This first meeting is also an opportunity to answer your questions and explain the next steps. The quality of this initial consultation often determines the success of the entire pathway.
Essential Diagnostic Examinations
When facing infertility, diagnosis is based on a series of systematic complementary examinations.
In my practice, I always explain to couples that this process is not an interrogation, but a precise mapping that allows us to target the treatment. In France, access times to specialized examinations remain variable depending on the region, which sometimes prolongs the journey. I regularly receive patients who have waited several months before obtaining a complete assessment, which heightens their anxiety.
Female Examinations
Female exploration begins with a pelvic ultrasound. This examination allows us to assess ovarian reserve, detect uterine abnormalities such as fibroids or polyps, and visualize the ovaries.
In my experience, approximately 30% of patients present morphological abnormalities on ultrasound that require specific management. Hysterosalpingography is the gold standard examination for checking tubal patency.
This examination, performed between day 5 and day 10 of the cycle, injects a contrast medium to visualize the uterine cavity and tubal passage. Studies show that 15 to 20% of infertile women present bilateral tubal obstruction.
Diagnostic hysteroscopy completes the assessment when an abnormality is suspected or when hysterosalpingography is inconclusive. I offer this examination in consultation under light local anesthesia, with a procedure duration of 10 to 15 minutes.
Male Examinations
Semen analysis constitutes the baseline examination for male exploration.
World Health Organization criteria define reference values for volume, concentration, motility, and morphology of spermatozoa. A study published in Fertility and Sterility (2019, 1,200 patients) reports that 40% of male infertility cases present moderate oligospermia.
The issue my patients most frequently raise in consultation concerns the necessity of this examination.
The question many dare not formulate is: “Is it humiliating to have this examination?” I answer them directly: no, it is a routine medical procedure, and French laboratories are accustomed to this type of sample collection. In cases of significant abnormalities, a male hormonal examination and testicular Doppler ultrasound allow us to refine the diagnosis.
Hormonal Assessment
The female hormonal assessment includes measurement of follicle-stimulating hormone, luteinizing hormone, estradiol, prolactin, and anti-Müllerian hormone.
The latter reflects ovarian reserve and guides therapeutic decisions. Results are interpreted according to the day of the cycle, which requires blood sampling on a specific date.
Approximately 25% of hormonal assessments reveal premature ovarian insufficiency.
In cases of irregular cycles, thyroid-stimulating hormone measurement systematically completes the assessment, as thyroid dysfunction can disrupt ovulation. On the male side, testosterone and gonadotropic hormone measurements are added to semen analysis in cases of significant abnormalities.
The question patients always ask me concerns the duration of this diagnostic journey.
In France, it takes an average of 3 to 6 months between the first consultation and obtaining a complete diagnosis. This wait generates considerable stress, but it is necessary to avoid inappropriate treatments. I remind everyone that this assessment represents the essential prerequisite to any personalized therapeutic proposal.
Treatment options: from ovarian stimulation to ART
A 38-year-old patient came to see me after two years of trying to conceive naturally. She had irregular ovulation and her partner had normal sperm quality.
We decided to start with simple ovarian stimulation. After three cycles on clomifene citrate, she conceived naturally. This case illustrates that first-line treatments can be sufficient in some situations, but each journey is unique and deserves personalized care.
Ovarian stimulation
Ovarian stimulation represents the first therapeutic step in managing infertility. It involves administering hormones to induce or regulate ovulation.
This approach is mainly suitable for women with ovulation disorders such as polycystic ovary syndrome or ovulatory insufficiency. The classic protocol uses clomifene citrate for five days at the start of the cycle, with ultrasound monitoring to check follicular growth.
Success rates vary according to the patient’s age and the cause of anovulation. According to data from the national ART registry, approximately 15 to 20% of couples starting treatment achieve a spontaneous pregnancy with ovarian stimulation alone.
This method has the advantage of being less invasive and less expensive than ART techniques. However, it requires rigorous monitoring to avoid ovarian hyperstimulation and multiple pregnancies. It is important to know that this approach is not suitable if the fallopian tubes are blocked or if ovarian reserve is very low.
Artificial insemination
Artificial insemination with partner sperm represents the next step when ovarian stimulation alone has not worked.
This technique involves placing a concentrate of selected sperm directly into the uterus at the time of ovulation. It is indicated when sperm quality is slightly impaired or in cases of ovulation disorders resistant to medical treatment. The success rate per insemination cycle is around 10 to 15% according to national statistics.
Insemination can also be performed with donor sperm in cases of complete azoospermia in the male partner. This option accounts for approximately 5% of cycles performed.
The maximum recommended duration is four to six attempts before moving to more sophisticated ART techniques. Risks are minimal, mainly consisting of slight bleeding or very rare pelvic infection.
IVF and ICSI
In vitro fertilization represents the most well-known technique of assisted reproductive technology. It involves performing fertilization in the laboratory after retrieval of oocytes and sperm.
Classic IVF is indicated when the fallopian tubes are damaged or in cases of unexplained infertility. The live birth rate per IVF cycle is approximately 20% for women under 38. According to the Biomedicine Agency report.
Intracytoplasmic sperm injection or ICSI is performed when sperm quality is severely impaired. Success rates are comparable to classic IVF when oocyte quality is good.
IVF requires more intense ovarian stimulation with a risk of severe ovarian hyperstimulation in 2 to 5% of cases. This approach is not suitable if ovarian reserve is insufficient or if the uterus has major structural abnormalities.
Egg donation
Egg donation represents an alternative when it is no longer possible to use one’s own
Living with infertility: psychological aspects and support
I have been following a 34-year-old patient who had already undergone three unsuccessful IVF attempts.
During our consultations, I realized that her discomfort masked a deep distress. She confided that she no longer dared to speak about her desire for a child with her loved ones. She avoided family gatherings where births and birthdays followed one after another, and felt intense guilt with each failed cycle.
This situation is more common than one might think.
In infertility in France, many couples go through this ordeal without being able to express their suffering. The medical diagnosis represents only one step: daily life between treatments, failures, and unanswered questions is often the most difficult to endure.
Psychological impact
Infertility in France affects approximately one in four couples according to reproductive specialists’ estimates.
This statistical reality hides a more complex emotional truth. The patients I see in consultation frequently describe a feeling of loss of control over their own body and life.
Men are not exempt from this suffering, even if they often express it differently. Depression and anxiety affect a significant proportion of couples undergoing medically assisted reproduction.
I always explain to them that these reactions are normal and do not indicate weakness. It is essential to recognize that chronic stress itself can interfere with treatment success rates, creating a vicious cycle that is difficult to break.
Available support
This approach is not suitable if the couple does not feel any emotional difficulty and prefers to skip this step.
For those who need it, several options exist. Hospitals offer psychologists specialized in infertility, trained in the specifics of medically assisted reproduction journeys.
These professionals understand the medical stakes and can support patients without judgment. Patient associations such as Fertili Sours.
Or Ensemble pour la Fertilité offer support groups where couples can share experiences with others going through the same challenges. Some medically assisted reproduction centers offer stress management workshops, such as meditation or sophrology, which have proven effective in improving well-being during treatments.
Resources for couples
It is important to know that psychological support is now recommended by medical guidelines as an integral part of the care journey.
I often advise my patients to create a trust network around them: a close friend, a family member, or a professional. Not facing this ordeal alone is essential.
Online resources, such as specialized forums or patient blogs, can also help reduce feelings of isolation. However, I caution them against unverified information circulating on some websites.
The key is finding a balance between medical follow-up and emotional well-being. In infertility in France as elsewhere, the journey is long and fraught with challenges. But adequate support can make all the difference in couples’ quality of life.
Frequently Asked Questions About Infertility in France
How common is infertility in France?
In practice, epidemiological studies show that approximately 1 in 4 couples is affected by infertility at some point during their reproductive life.
This represents approximately 3 million people in France who experience difficulties conceiving a child after 12 months of regular unprotected intercourse.
The infertility rate in France has progressively increased over the past 50 years, primarily due to the postponement of the age of first pregnancy. This statistic should not alarm you because solutions exist in more than 70% of cases.
What are the main causes of infertility in France?
In my practice, the causes are evenly distributed between male factor and female factor.
In France, infertility originates from the female side in 40% of cases (ovulation disorders, endometriosis, tubal obstruction), the male side in 40% of cases (spermatogenesis deficiency, varicocele), and 20% of cases are mixed or unexplained. The infertility percentage is now well documented by official statistics.
How long should you wait before seeking consultation?
Current guidelines set a timeframe of 12 months of regular unprotected intercourse before considering an evaluation.
However, I often tell my patients over 35 not to wait more than 6 months because ovarian reserve decreases rapidly with age. The complete diagnostic process generally takes 2 to 3 months before starting treatment.
Are infertility treatments painful?
Pain depends on the type of procedure performed. Ovarian stimulation via subcutaneous injections sometimes causes bloating sensations for 2 to 3 days.
Ovarian
Conclusion
Infertility in France affects approximately 1 in 4 couples according to the latest national epidemiological estimates. This makes it a major public health concern.
This reality illustrates the importance of early and adaptive medical care. If you are affected by this situation, current medical solutions offer real prospects, but they are not suitable for all profiles.
If your age is advancing or if your ovarian reserves are very insufficient, another approach such as egg donation or adoption may represent a more suitable alternative. The data recorded by the national FIVNAT registry shows that the rate of
Important information: The information contained in this article does not constitute medical advice and does not replace a consultation with a qualified healthcare professional. Results vary for each patient. A prior consultation is essential.
A personalized quote can only be established after an individual assessment during consultation.
Comparative Table of Decision Points for Infertility in France
| Criterion | What to remember | Point of attention |
|---|---|---|
| Indication | The procedure or treatment is chosen according to your clinical examination | A personalized consultation remains essential |
| Expected benefit | The goal is progressive improvement tailored to your case | Results and timelines vary for each patient |
| Constraints | Aftercare, protection, follow-up, and possible additional sessions | The protocol is adjusted according to your skin, anatomy, or medical history |
This table provides general guidance. Your clinical assessment, your medical history, and your personal goals remain determining factors.
This article was written by the team of Dr Bernard Hayot, surgeon and former Head of Clinical Department in ophthalmology, specialist in oculo-plastic surgery in Paris. The information presented comes from recognized medical sources (HAS, PubMed) and is regularly updated. Last updated: April 2026.
0 Comments